The current standard of care for HCV is a combination of PEGylated–interferon (PEG–IFN) and ribavirin. PEG-IFNs available on the market include PEG–Intron (Schering–Plough) and Pegasys ...

Janssen HLA et al. (2005) Pegylated interferon α-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial. Lancet 365: 123–129 Janssen and ...

Inpegsomatropin is under clinical development by Xiamen Amoytop Biotech and currently in Phase II for Turner Syndrome.

Oral Presentations The Company will present its lead asset, PP-007 (PEGylated carboxyhemoglobin bovine, also known as SANGUINATE ®), a novel clinical stage biopharmaceutical product that is ...